FDA Clears Expanded Labeling for the Invisalign System

SANTA CLARA, Calif., Jan. 12 /PRNewswire-FirstCall/ — Align Technology, Inc. (NASDAQ: ALGN) today announced that the U.S. Food and Drug Administration (FDA) has cleared new labeling for the Invisalign system, thereby removing the permanent dentition limitation from the indications for use. In addition, certain conditions previously listed as contraindications will now be listed as precautions. [...]